PNC Financial Services (NYSE: PNC ) has completed its CEO succession. Effective today, William Demchak is the company's chief executive. He replaces James Rohr, who will stay on with the company in the newly created position of executive chairman.
Demchak has been with the banking group since 2002, when he joined PNC as CFO. He was named head of corporate and institutional banking in 2005 and then promoted to senior vice president in 2009 and head of all PNC businesses the following year. He became president last year and this past February joined the board of directors.
Before his time at PNC, Demchak was head of structured finance and credit portfolio at JPMorgan Chase (NYSE: JPM ) . At present, he also serves as a director of BlackRock.��
Best Communications Equipment Companies To Watch For 2015: GlaxoSmithKline PLC(GSK)
GlaxoSmithKline plc, together with its subsidiaries, engages in the discovery, development, manufacture, and marketing of pharmaceutical products, over the counter (OTC) medicines, and health-related consumer products worldwide. It offers pharmaceutical products in various therapeutic areas comprising respiratory, HIV, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, oncology and emesis, vaccines, and dermatologicals. The company provides prescription medicines to treat a range of conditions, including infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer. It also markets a range of vaccines to prevent life-threatening or crippling illnesses, such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza, and bacterial meningitis. In addition, the company provides OTC medicines, including Panadol, a paracetamol-based treatment of headache and joi nt pain, fever, and cold symptoms; Gaviscon, a range of antacid products that relieve heartburn due to acid reflux; and NicoDerm, NiQuitin CQ, Nicabate, and Nicorette for the treatment of nicotine withdrawal as an aid to quit smoking. Further, it offers oral healthcare products comprising Sensodyne, a range of toothpastes and toothbrushes for the prevention of dental sensitivity; Aquafresh, a range of toothpastes, toothbrushes, and mouthwashes; and Polident, Poligrip, and Corega, which are denture adhesives and cleansers. Additionally, the company provides nutritional healthcare products consisting of Lucozade, an energy and sports drinks for energy and hydration; Horlicks, a malted, milk-based drink and food for nutrition application; and Ribena, an apple, orange, raspberry, and pomegranate flavored fruit drink, as well as markets skincare products. GlaxoSmithKline plc was incorporated in 1999 and is headquartered in Brentford, United Kingdom.
Advisors' Opinion:- [By Mark Rogers]
LONDON -- The shares of�GlaxoSmithKline� (LSE: GSK ) (NYSE: GSK ) were flat at 1,676 pence early this afternoon after the FTSE pharmaceutical giant lifted its first-quarter dividend by 6%.
- [By Maxx Chatsko]
That will provide a solid boost to sales for the best-selling pneumococcal vaccine, which brought in $877 million in the first quarter. Prevnar13 already easily competes with Synflorix from GlaxoSmithKline (NYSE: GSK ) and Prevnar/Prevenar from Wyeth. Synflorix protects against 10 types of the bacterium and generated sales of just $116 million in the first quarter, while Prevnar (from Wyeth) protects against just seven. Pfizer's Prevnar13 protects against, you guessed it, 13 types -- giving it the broadest protection of any such vaccine. An expanded indication will further cement its stranglehold on the market and make it the only therapy approved for nearly any age group. �
- [By Brian Orelli]
For instance,�GlaxoSmithKline's (NYSE: GSK ) �dividend yield is around 4.5%. The pharma faces a major patent cliff, with many of its top-selling drugs facing generic competition fairly soon. Investors require the higher dividend yield to justify owning shares since they know the underlying stock price might not go anywhere.
- [By Brian Orelli]
By comparison, GlaxoSmithKline's (NYSE: GSK ) fish oil Lovaza racked up $229 million in the U.S. in the first quarter. There's certainly potential for Amarin to get there, eventually, but it'll take a while. Quite a bit of Lovaza's sales come from off-label use in patients that only have moderately high triglyceride levels. Those patients could use Vascepa, but I suspect that doctors will want a little more experience using the drug before prescribing it off label.
5 Best Regional Bank Stocks To Watch Right Now: Webxu Inc (WBXU)
WebXU, Inc. (WebXU), incorporated on July 16, 2010, is a media company. The Company develops, acquires and integrates consumer-oriented businesses in the online customer acquisition and e-commerce field, focusing on operational improvement and augmenting of management resources. The Company also provides marketing solutions for online businesses, media agencies and marketers. The Company generates revenue by providing advertiser clients with targeted consumer traffic. In December 2012, the Company acquired M.T. Performance Marketing, Inc. (MediaTrust). In May 2013, Webxu Inc acquired BarNone Inc.
The Company�� wholly owned subsidiaries include Bonus Interactive Inc. and Lot6 Media, Inc. Bonus Interactive Inc. is engaged in the business of customer acquisition and retention programs in both the online and offline arenas. Lot6 Media, Inc. provides a variety of solutions for online businesses, media agencies, and marketers.
Advisors' Opinion:- [By Peter Graham]
Last Friday, small cap marijuana stock Petrotech Oil & Gas Inc (OTCMKTS: PTOG) surged 65.7% while OSL Holdings Inc (OTCMKTS: OSLH) and WebXU Inc (OTCMKTS: WBXU) sank 20.47% and 12.02%, respectively, thanks in part to news and (in the case of two of these small caps) some paid promotions or investor relations type of activities. But will these three small cap marijuana stocks be able to sustain their highs or come out of rehab this week? Here is a reality check before you look for a quick high with them:
5 Best Regional Bank Stocks To Watch Right Now: Poly Shield Technologies Inc (SHPR)
Poly Shield Technologies Inc. (Poly Shield), incorporated on March 2, 2000, is a research, development and marketing company providing environmental, energy saving and durability solutions. The Company's are designed and manufactured under the advanced bio-scrubber technology and includes a line of protective fluoropolymer coatings. Poly Shield�� fluoropolymer products are manufactured at a production facility in Florida. Poly Shield�� manufactured fluoropolymer coatings are used in a number of different industries including marine, aerospace, oilfield, industrial, commercial, and residential applications. In addition, Poly Shield offers a line of antimicrobial coatings for use in hospital or food industries. In December 2013, Poly Shield Technologies Inc sold New World Technologies Group, Inc. to Viveros.
The Company's products include bio-scrubber, supershield, superiorshield and microshield. Its products are used in aerospace, cruise ship lines, marine, military, oil, and energy production industries. The Company's bio-scrubber is designed to remove alkali metals from fuel in an effort to protect gas turbines from high temperature corrosion. The technology has been installed on active ships within the cruise line industry.
SuperShield is a fluoropolymer coating that is formulated to work with a variety of residential, commercial, industrial and marine applications. It is a fluoroplymer resin that offers weathering ability and the choice of temperature curing. Its flagship product, SuperShield 100, containing fluoropolymer resins provides up to a 50 year service life on a steel and metal surfaces. Its SuperShield S is superhydrophobic and superoleophobic, with characteristic complex micro and nanoscopic surface, which minimizes adhesion. SuperShield S100 is also superhydrophobic and superoleophobic. SuperShield S100 is provides 50 year service life. The ultimate anti-fouling coating for ship hulls, oilfield rigs, heavy equipment, airplanes, bridges, etc.
! SuperiorShield is protective and energy saving roof coatings. Its superiorShield coating reduces heat transfer through infrared radiation, conduction and convection. SuperiorShield has the capability to reflect 90% of the suns ultraviolet (UV) rays.
MicroShield is a anti-microbial coating. MicroShield is an active antibacterial destroying the cell membrane and inducing oxidative deoxyribonucleic acid (DNA) and protein damage of microbes. It also acts as a bacteriostat, virostat and fungistat, inhibiting bacterial, viral and fungal growth.
Advisors' Opinion:- [By Peter Graham]
Small cap stocks Soul and Vibe Interactive Inc (OTCBB: SOUL), Globalstar, Inc (OTCMKTS: GSAT) and Poly Shield Technologies Inc (OTCBB: SHPR) have been getting some attention lately in various investment newsletters or investor alerts with at least two of these stocks being the subject of some sort of paid stock promotional or investor relations type of activities. With that in mind, just how hot are these three small cap stocks for investors or traders? Here is a quick reality check:
5 Best Regional Bank Stocks To Watch Right Now: Health Net Inc. (HNT)
Health Net, Inc., through its subsidiaries, provides managed health care services. The company offers commercial health care products, such as health maintenance organization plans through contracts with participating network physicians, hospitals, and other providers; preferred provider organization plans that provide coverage for services received from health care provider; and point of service plans. It also provides Medicare products, including Medicare advantage plans with and without prescription drug coverage; and Medicare supplement products that supplement fee-for-service Medicare coverage. In addition, the company offers Medicaid and related products; indemnity insurance products; auxiliary non-health products, such as life, accidental death and dismemberment, dental, vision, and behavioral health insurance; and other specialty services and products comprising pharmacy benefits, behavioral health, dental, and vision products and services, as well as managed care products for hospitals, health plans, and other entities. Further, it engages in government-sponsored managed care federal contract with the Department of Defense under the TRICARE program in the North Region; and other health care, mental health, and behavioral health government contracts. The company provides administrative services comprising provider network and referral management, medical and disease management, enrollment, customer service, clinical support service, and claims processing service to military health system eligible beneficiaries. It serves approximately 5.4 million individuals in the United States through group, individual, Medicare, Medicaid, the U.S. Department of Defense, and Veterans Affairs programs. Health Net, Inc. was founded in 1979 and is headquartered in Woodland Hills, California.
Advisors' Opinion:- [By Sean Williams]
What: Shares of Health Net (NYSE: HNT ) , a managed health-care provider, jumped higher by as much as 18% following the release of the company's first-quarter earnings results. Shares have since given back a majority of their gains and are up "just" 7% as of this writing.
- [By Roberto Pedone]
Health Net (HNT) is an integrated managed care organization that delivers managed health care services through health plans and government-sponsored managed care plans. This stock closed up 2.9% at $32.51 in Thursday's trading session.
Thursday's Volume: 1.17 million
Three-Month Average Volume: 665,534
Volume % Change: 65%From a technical perspective, HNT jumped higher here right above its 50-day moving average of $31.37 with above-average volume. This stock has been uptrending for the last few weeks, with shares moving higher from its low of $29.11 to its intraday high of $32.80. During that move, shares of HNT have been consistently making higher lows and higher highs, which is bullish technical price action. That move is starting to push shares of HNT within range of triggering a big breakout trade. That trade will hit if HNT manages to take out some near-term overhead resistance levels at $33.61 to its 52-week high at $33.70 with high volume.
Traders should now look for long-biased trades in HNT as long as it's trending above its 50-day at $31.37 and then once it sustains a move or close above those breakout levels with volume that's near or above 665,534 shares. If that breakout hits soon, then HNT will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $38 to its three-year high at $41.22.
No comments:
Post a Comment